Trademark Overview
On Friday, October 4, 2024, a trademark application was filed for METANOVA with the United States Patent and Trademark Office. The USPTO has given the METANOVA trademark a serial number of 98786472. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, April 9, 2025. The METANOVA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for inducing erections; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating resp...
Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Advanced product research in the field of artificial intelligence (AI); Biological research and analysis; Chemical research and analysis; Drug discovery services; Medical research in the field of oncology; Pharmaceutical drug development services; Providing information relating to computer technology and programming via a website; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services in the field of pharmaceutical preparations; Research and development services of new pharmaceutical products; Research in the field of artificial intelligence; Research in the field of artificial intelligence (AI); Research in the field of ar...
